株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のインスリン皮下持続注入治療機器(CSITD)市場:2019~2023年

Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023

発行 TechNavio (Infiniti Research Ltd.) 商品コード 756746
出版日 ページ情報 英文 111 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.36円で換算しております。
Back to Top
世界のインスリン皮下持続注入治療機器(CSITD)市場:2019~2023年 Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023
出版日: 2018年12月03日 ページ情報: 英文 111 Pages
概要

世界のインスリン皮下持続注入治療機器(CSITD)市場は2023年までにCAGR9%で拡大すると予測されています。ベンダーは利用可能な技術および振興技術の製品への導入のために戦略的提携を進めています。これが市場の成長につながっています。

当レポートでは、世界のインスリン皮下持続注入治療機器(CSITD)市場について調査し、市場の動向とセグメント別概要、地域別動向、および市場に参入主要企業のプロファイルと競合動向についてまとめています。

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 市況

第4章 市場規模

  • 市場の定義
  • 市場規模
  • 市場規模と予測

第5章 ファイブフォース分析

第6章 製品別市場セグメンテーション

  • セグメンテーション
  • 比較
  • 繋留
  • パッチ
  • 市場の機会

第7章 顧客動向

第8章 地域別動向

  • 地域別セグメンテーション
  • 地域別比較
  • 南北アメリカ
  • アジア太平洋地域
  • 欧州・中東・アフリカ
  • 市場の機会

第9章 促進因子と課題

第10章 市場動向

第11章 ベンダー環境

第12章 ベンダー分析

  • 網羅されるベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care

第14章 付録

図表
  • Exhibit 01: Years in consideration
  • Exhibit 02: Global medical devices market
  • Exhibit 03: Segments of global medical devices market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: Product - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by product
  • Exhibit 19: Tethered - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Tethered - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Patch - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Patch - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Market opportunity by product
  • Exhibit 24: Customer landscape
  • Exhibit 25: Market share by geography 2018-2023 (%)
  • Exhibit 26: Geographic comparison
  • Exhibit 27: Americas - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 28: Americas - Year-over-year growth 2019-2023 (%)
  • Exhibit 29: Top 3 countries in Americas
  • Exhibit 30: EMEA - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 31: EMEA - Year-over-year growth 2019-2023 (%)
  • Exhibit 32: Top 3 countries in EMEA
  • Exhibit 33: APAC - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: APAC - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Top 3 countries in APAC
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Decision framework
  • Exhibit 39: Patients diagnosed with diabetes in US 1995-2015
  • Exhibit 40: Rates of children aged under 14 years with type 1 diabetes per 1,000 population 2015
  • Exhibit 41: Product launches
  • Approval year
  • Regulatory body
  • Description
  • Exhibit 42: Product recalls in global CSITD market
  • Exhibit 43: Impact of drivers and challenges
  • Exhibit 44: Vendor landscape
  • Exhibit 45: Landscape disruption
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Market positioning of vendors
  • Exhibit 49: Cellnovo - Vendor overview
  • Exhibit 50: Cellnovo - Organizational developments
  • Exhibit 51: Cellnovo - Geographic focus
  • Exhibit 52: Cellnovo - Key offerings
  • Exhibit 53: F. Hoffmann-La Roche - Vendor overview
  • Exhibit 54: F. Hoffmann-La Roche - Business segments
  • Exhibit 55: F. Hoffmann-La Roche - Organizational developments
  • Exhibit 56: F. Hoffmann-La Roche - Geographic focus
  • Exhibit 57: F. Hoffmann-La Roche - Segment focus
  • Exhibit 58: F. Hoffmann-La Roche - Key offerings
  • Exhibit 59: Insulet - Vendor overview
  • Exhibit 60: Insulet - Organizational developments
  • Exhibit 61: Insulet - Geographic focus
  • Exhibit 62: Insulet - Key offerings
  • Exhibit 63: Medtronic - Vendor overview
  • Exhibit 64: Medtronic - Business segments
  • Exhibit 65: Medtronic - Organizational developments
  • Exhibit 66: Medtronic - Geographic focus
  • Exhibit 67: Medtronic - Segment focus
  • Exhibit 68: Medtronic - Key offerings
  • Exhibit 69: Tandem Diabetes Care - Vendor overview
  • Exhibit 70: Tandem Diabetes Care - Organizational developments
  • Exhibit 71: Tandem Diabetes Care - Key offerings
  • Exhibit 72: Validation techniques employed for market sizing
  • Exhibit 73: List of abbreviations
目次
Product Code: IRTNTR30346

About this market:

The rising partnerships to gain prominence in the market. Vendors are entering into strategic alliances and partnerships for integration of available and emerging technologies into their products. Such partnerships will help the market to grow. Technavio's analysts have predicted that the continuous subcutaneous insulin therapy devices market will register a CAGR of more than 9% by 2023.

Market Overview:

Rise in awareness about diabetes

The rise in prevalence of diabetes has resulted in increasing awareness efforts by various organizations globally. Programs such as the Diabetes Activities Under State Public Health Actions increase the participation of people.

Rise in product recalls

The growth of the market is hindered by product recalls. Product recalls affect the sales of a company negatively, which results in a decline in it market share. Also, they affect the brand image of vendors, thereby reducing profit margins.

For the detailed list of factors that will drive and challenge the growth of the continuous subcutaneous insulin therapy devices market during the 2019-2023, view our report.

Competitive Landscape:

The market appears to be concentrated and with the presence of several companies including Medtronic and Tandem Diabetes Care the competitive environment is quite intense. Factors such as the rising partnerships and the rise in awareness about diabetes, will provide considerable growth opportunities to continuous subcutaneous insulin therapy devices manufactures. Cellnovo, F. Hoffmann-La Roche, Insulet, Medtronic, and Tandem Diabetes Care are some of the major companies covered in this report.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Tethered - Market size and forecast 2018-2023
  • Patch - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

  • Technological advances
  • Increase in grants for product development
  • Rise in strategic partnerships

PART 11: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 12: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Cellnovo
  • F. Hoffmann-La Roche
  • Insulet
  • Medtronic
  • Tandem Diabetes Care

PART 13: APPENDIX

  • Research methodology
  • List of abbreviations
Back to Top